Results

Total Results: 3,881 records

Showing results for "phase".

3681. Serologic Screening for Genital Herpes: An Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/aHpXYasjc3n6zhaTtoWMwK
      August 01, 2016 - genital herpes in the United States, and a list of studies that were excluded during the full-text review phase

3682. Migraine-Prevention Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
      June 01, 2013 - Of nine phase 3 studies involving exclusively children, none posted the results on ClinicalTrials.gov

3683. Weight-Gain-Prevention Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
      January 01, 2020 - Crossover studies must have reported at least 1 year of weight change in each phase of the crossover

3684. Cer-238-Cervical-Ripening-Appendix-E-2 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
      January 01, 2017 - vs. 15.38% (4/26) RR 1.63 (95% CI 0.52 to 5.07) (all CD in OP for failure to progress in the active phase

3685. Title Page (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/p20hs015426-lozzio-final-report-2005.pdf
      January 01, 2005 - Women Infants and Children (WIC) and TennCare EPSDT data will be a major goal of the implementation phase

3686. TeamSTEPPS for Improving Diagnosis Participant Workbook (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dxsafety-particpant-workbook.pdf
      February 04, 2022 - Assess maturity phase in your practice setting and identify strengths and opportunities to increase

3687. References | Agency for Healthcare Research and Quality
      www.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-current-state-references.html
      January 01, 2024 - Defining and managing the preanalytical phase with FMECA: automation and/or “human” control.

3688. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/9Ks34K-BnsDSBK4MYDATYS
      August 09, 2016 - , participants had group visits and indi- vidual family visits, followed by a 2.5-year maintenance phase

3689. Archived: Evidence Summary: Collaborative Modeling of U.S. Breast Cancer Screening Strategies: Breast Cancer: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-collaborative-modeling-of-us-breast-cancer-/breast-cancer-screening-january-2016
      January 11, 2016 - Screening attendance (routine screening) 0.994 0.006 (0.009, 0.012) 1 Week Diagnostic phase

3690. Archived: Final Evidence Summary: Lung Cancer: Screening, May 2004 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary35/lung-cancer-screening-2004
      May 15, 2004 - mandatory testing 3 1 and 2 4 Exp clinical trials or clinical trials.mp clinical trials, phase

3691. Screening for Postmenopausal Osteoporosis: A Summary of the Evidence (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/2kM7LY6ccceVo8bmdUXhYm
      September 01, 2002 - The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995:1437-1443. 111.

3692. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/nmcMhEwWT9BncBBBQQN6Uf
      December 01, 2015 - If the tumor is in the preclinical phase and above the screen detection threshold at the time of screening … Until death Screening attendance (routine screening) 0.994 0.006 (0.009, 0.012) 1 Week Diagnostic phase

3693. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
      www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
      December 01, 2015 - If the tumor is in the preclinical phase and above the screen detection threshold at the time of screening … Until death Screening attendance (routine screening) 0.994 0.006 (0.009, 0.012) 1 Week Diagnostic phase

3694. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/jmCXJwxefa67VY4NfD8gUg
      June 26, 2018 - Liberman UA, Weiss SR, Bröll J, et al; Alendronate Phase III Osteoporosis Treatment Study Group. … osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase

3695. 15 Crosscutting Potential High Impact June 2012 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_june_2012.pdf
      January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase

3696. The Patient-Centered Clinical Decision Support Learning Network: Improving the Dissemination of PCOR in Patient-Centered Clinical Decision Support - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/u18hs024849-blumenfeld-final-report-2020.pdf
      January 01, 2020 - Our completion of phase two of the website enabled improved functioning of governance bodies, distribution

3697. Implementation and Evaluation of psPRO: Person-specific Patient-Reported Outcome Assessments for Patients in HIV Care living with Multiple Chronic Conditions - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/u18hs026154-crane-final-report-2023.pdf
      January 01, 2023 - We expanded the Phase 1 interviews to gather provider input regarding specific chronic conditions and

3698. Evidence Summary: Speech and Language Delay and Disorders in Children: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening
      January 23, 2024 - A phase II trial of telehealth delivery of the Lidcombe Program of Early Stuttering Intervention.

3699. Archived: High Blood Cholesterol and Other Lipid Abnormalities: Screening, 1996 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-cholesterol-other-lipid-abnormalities-screening-1996
      January 01, 1996 - Daily dietary fat and total food-energy intake—Third National Health and Nutrition Examination Survey, Phase

3700. Archived: Evidence Summary: Osteoporosis: Screening, 2002 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/osteoporosis-screening-2002
      September 17, 2002 - The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995:1437-43. 111.